{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:16:49Z","timestamp":1773886609132,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.tracli.2017.06.002","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T14:45:38Z","timestamp":1498056338000},"page":"240-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["NGS and blood group systems: State of the art and perspectives"],"prefix":"10.1016","volume":"24","author":[{"given":"Y.","family":"Fichou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"F\u00e9rec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2017.06.002_bib0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/voxs.12002","article-title":"Use of genomics for decision-making in transfusion medicine: laboratory practice","volume":"8","author":"Peyrard","year":"2013","journal-title":"ISBT Sci Ser"},{"key":"10.1016\/j.tracli.2017.06.002_bib0170","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/bs.acc.2016.06.006","article-title":"Advances in blood typing","volume":"77","author":"Quraishy","year":"2016","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.tracli.2017.06.002_bib0175","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/voxs.12339","article-title":"Cost-effectiveness of implementing molecular immunohematology","volume":"12","author":"Denomme","year":"2017","journal-title":"ISBT Sci Ser"},{"key":"10.1016\/j.tracli.2017.06.002_bib0180","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tracli.2013.02.012","article-title":"Molecular biology methods in immunohematology","volume":"20","author":"Tournamille","year":"2013","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2017.06.002_bib0185","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.transci.2014.02.012","article-title":"Molecular blood grouping of donors","volume":"50","author":"St-Louis","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2017.06.002_bib0190","series-title":"Methods in molecular biology: molecular typing of blood cell antigens","year":"2015"},{"key":"10.1016\/j.tracli.2017.06.002_bib0195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/voxs.12165","article-title":"Molecular tools for investigating immunohaematology problems","volume":"10","author":"Peyrard","year":"2015","journal-title":"ISBT Sci Ser"},{"key":"10.1016\/j.tracli.2017.06.002_bib0200","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/voxs.12311","article-title":"Next-generation sequencing for blood group genotyping","volume":"12","author":"Fichou","year":"2017","journal-title":"ISBT Sci Ser"},{"key":"10.1016\/j.tracli.2017.06.002_bib0205","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1423-0410.2010.01444.x","article-title":"Overcoming methodical limits of standard RHD genotyping by next-generation sequencing","volume":"100","author":"Stabentheiner","year":"2011","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2017.06.002_bib0210","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1111\/trf.12172","article-title":"Next-generation sequencing: proof of concept for antenatal prediction of the fetal Kell blood group phenotype from cell-free fetal DNA in maternal plasma","volume":"53","author":"Rieneck","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.002_bib0215","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/bjh.13084","article-title":"Next-generation sequencing is a credible strategy for blood group genotyping","volume":"167","author":"Fichou","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2017.06.002_bib0220","first-page":"1","article-title":"A preliminary evaluation of next-generation sequencing as a screening tool for targeted genotyping of erythrocyte and platelet antigens in blood donors","volume":"10","author":"Orzi\u0144ska","year":"2017","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tracli.2017.06.002_bib0225","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.V92.7.2237","article-title":"A novel mutation in the coding sequence of the FY*B allele of the Duffy chemokine receptor gene is associated with an altered erythrocyte phenotype","volume":"92","author":"Parasol","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.06.002_bib0230","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/trf.13416","article-title":"Comprehensive red blood cell and platelet antigen prediction from whole genome sequencing: proof of principle","volume":"56","author":"Lane","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.002_bib0235","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/trf.14054","article-title":"Evaluation of targeted exome sequencing for 28 protein-based blood group systems, including the homologous gene systems, for blood group genotyping","volume":"57","author":"Schoeman","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.002_bib0240","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12864-017-3575-z","article-title":"2.7 million samples genotyped for HLA by next generation sequencing: lessons learned","volume":"18","author":"Sch\u00f6fl","year":"2017","journal-title":"BMC Genomics"},{"key":"10.1016\/j.tracli.2017.06.002_bib0245","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12864-016-2687-1","article-title":"ABO allele-level frequency estimation based on population-scale genotyping by next generation sequencing","volume":"17","author":"Lang","year":"2016","journal-title":"BMC Genomics"},{"key":"10.1016\/j.tracli.2017.06.002_bib0250","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.tracli.2011.09.001","article-title":"Relevance of RH variants in transfusion of sickle cell patients","volume":"18","author":"Noizat-Pirenne","year":"2011","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2017.06.002_bib0255","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.06.002_bib0260","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bcmd.2013.11.003","article-title":"Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease","volume":"52","author":"Reid","year":"2014","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.tracli.2017.06.002_bib0265","first-page":"72","article-title":"Variant RH alleles and Rh immunization in patients with sickle cell disease","volume":"13","author":"Sippert","year":"2015","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tracli.2017.06.002_bib0270","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1423-0410.2009.01185.x","article-title":"DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease","volume":"97","author":"Ribeiro","year":"2009","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2017.06.002_bib0275","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/trf.12623","article-title":"How do we use molecular red blood cell antigen typing to supplement transfusion testing","volume":"54","author":"Sapatnekar","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.002_bib0280","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/trf.12582","article-title":"How we incorporate molecular typing of donors and patients into our hospital transfusion service","volume":"54","author":"Shafi","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.06.002_bib0285","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.transci.2016.11.007","article-title":"Emerging strategies of blood group genotyping for patients with hemoglobinopathies","volume":"56","author":"Belsito","year":"2017","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2017.06.002_bib0290","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bcmd.2017.03.014","article-title":"RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients","volume":"65","author":"Dezan","year":"2017","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.tracli.2017.06.002_bib0295","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/vox.12432","article-title":"The experience of extended blood group genotyping by next-generation sequencing: investigation of patients with sickle-cell disease","volume":"111","author":"Fichou","year":"2016","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2017.06.002_bib0300","first-page":"96","article-title":"MNS blood group systems","year":"2013"},{"key":"10.1016\/j.tracli.2017.06.002_bib0305","first-page":"182","article-title":"Rh and RHAG blood group systems","year":"2013"},{"key":"10.1016\/j.tracli.2017.06.002_bib0310","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/jhg.2015.102","article-title":"The impact of next-generation sequencing technologies on HLA research","volume":"60","author":"Hosomichi","year":"2015","journal-title":"J Hum Genet"},{"key":"10.1016\/j.tracli.2017.06.002_bib0315","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.humimm.2016.04.002","article-title":"Next-generation sequencing of the HLA locus: methods and impacts on HLA typing, population genetics and disease association studies","volume":"77","author":"Carapito","year":"2016","journal-title":"Hum Immunol"},{"key":"10.1016\/j.tracli.2017.06.002_bib0320","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.gpb.2016.05.004","article-title":"Oxford Nanopore MinION sequencing and genome assembly","volume":"14","author":"Lu","year":"2016","journal-title":"Genomics Proteomics Bioinformatics"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782017300824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782017300824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:36:35Z","timestamp":1761129395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782017300824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1246782017300824"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2017.06.002","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NGS and blood group systems: State of the art and perspectives","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2017.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}